China
Nuance Pharma Expands Bentrio® Nasal Spray Launch in Asia, Files for Mainland China Approval
Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for ...
September 24, 2024 | News
Kangpu Biopharmaceuticals Successfully Completes Bridging Clinical Study of KPG-818 in Healthy Subjects in China
Kangpu Biopharmaceuticals, a clinical-stage company based in Hefei, China, announced that the Company has successfully completed a bridging clinical s...
September 23, 2024 | News
CD Biopharma Receives FDA Clearance for IND Application of CD-001, Paving the Way for Phase I Clinical Trial
CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application...
September 23, 2024 | News
Henlius Receives Positive CHMP Opinion for HANSIZHUANG (Serplulimab) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer in Europe
Shanghai Henlius Biotech, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued ...
September 23, 2024 | News
Concord Medical's Guangzhou Cancer Center Secures License for Proton Therapy Equipment
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...
September 17, 2024 | News
ImmVira Reports Promising Phase I Results for Oncolytic Virus MVR-T3011 in BCG-Failure Bladder Cancer
ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk B...
September 16, 2024 | News
Avistone Biotechnology Presents Promising Clinical Results of Dual c-MET and EGFR Inhibitors for NSCLC at WCLC 2024
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...
September 11, 2024 | News
Ractigen Therapeutics Reports Positive Clinical Data from ALS-SOD1 Trial of RAG-17
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced promising clinical data from an Inve...
September 11, 2024 | News
Nuance Pharma Completes Patient Recruitment for Pivotal ENHANCE-CHINA COPD Study
Nuance Pharma announced it has completed the recruitment of patients for the ENHANCE-CHINA (NCT05743075) study, after planned number of patients have ...
September 11, 2024 | News
GenAssist Doses First DMD Patient with Pioneering Base Editing Drug GEN6050X in Clinical Trial
GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X injection, in an investigator-initiated trial (IIT). ...
September 10, 2024 | News
Regenity Biosciences Secures NMPA Approval for Matrixflex™ Collagen Dental Membrane in China
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners portfolio company, today announced it has received regulatory ap...
September 05, 2024 | News
Skyline Therapeutics Secures FDA Orphan Drug Designation for Gene Therapy SKG1108 to Treat Retinitis Pigmentosa
Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, announced ...
September 04, 2024 | News
Innovent Biologics Receives FDA Fast Track Designation for PD-1/IL-2α Bispecific Antibody in Advanced Melanoma Treatment
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
September 04, 2024 | News
Simcere Zaiming and TargetRx Forge Strategic Partnership for Groundbreaking ALK/ROS1 Dual Inhibitor in China
Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group (2096.HK), announced a collaboration agreement with Shenzhen TargetRx In...
September 03, 2024 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
